Gates Foundation pledges $120 million to boost access to COVID-19 drug The Bill & Melinda Gates Foundation has announced a commitment of up to $120 million to accelerate access for lower-income countries to the investigational antiviral drug molnupiravir. To be allocated in consultation with partner organizations, the funding will support efforts to develop and manufacture generic versions…
Read more
Gates Foundation pledges $120 million to boost access to COVID-19 drug
